Nephros, Inc.
NEPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $14,162 | $14,238 | $9,975 | $10,217 |
| % Growth | -0.5% | 42.7% | -2.4% | – |
| Cost of Goods Sold | $5,439 | $5,833 | $5,244 | $4,584 |
| Gross Profit | $8,723 | $8,405 | $4,731 | $5,633 |
| % Margin | 61.6% | 59% | 47.4% | 55.1% |
| R&D Expenses | $906 | $873 | $1,255 | $1,498 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7,676 | $8,911 | $7,593 | $7,195 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $135 | $214 | $218 | $192 |
| Operating Expenses | $8,717 | $9,998 | $9,066 | $8,885 |
| Operating Income | $6 | -$1,593 | -$4,335 | -$3,252 |
| % Margin | 0% | -11.2% | -43.5% | -31.8% |
| Other Income/Exp. Net | $83 | $18 | $58 | $468 |
| Pre-Tax Income | $89 | -$1,575 | -$4,277 | -$2,784 |
| Tax Expense | $15 | $0 | $0 | $0 |
| Net Income | $74 | -$1,575 | -$7,382 | -$4,107 |
| % Margin | 0.5% | -11.1% | -74% | -40.2% |
| EPS | 0.007 | -0.15 | -0.72 | -0.41 |
| % Growth | 104.7% | 79.2% | -75.6% | – |
| EPS Diluted | 0.007 | -0.15 | -0.72 | -0.41 |
| Weighted Avg Shares Out | 10,525 | 10,386 | 10,297 | 10,018 |
| Weighted Avg Shares Out Dil | 10,602 | 10,386 | 10,297 | 10,018 |
| Supplemental Information | – | – | – | – |
| Interest Income | $94 | $64 | $14 | $10 |
| Interest Expense | $1 | $2 | $20 | $41 |
| Depreciation & Amortization | $137 | $214 | $571 | $252 |
| EBITDA | $227 | -$1,359 | -$3,686 | -$2,491 |
| % Margin | 1.6% | -9.5% | -37% | -24.4% |